107 related articles for article (PubMed ID: 12565957)
21. Echinocandins: The Expanding Antifungal Armamentarium.
Aguilar-Zapata D; Petraitiene R; Petraitis V
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S604-11. PubMed ID: 26567277
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and structure-activity relationship studies of novel fused heterocycles-linked triazoles with good activity and water solubility.
Cao X; Sun Z; Cao Y; Wang R; Cai T; Chu W; Hu W; Yang Y
J Med Chem; 2014 May; 57(9):3687-706. PubMed ID: 24564525
[TBL] [Abstract][Full Text] [Related]
23. Novel pyridobenzimidazole derivatives exhibiting antifungal activity by the inhibition of beta-1,6-glucan synthesis.
Takeshita H; Watanabe J; Kimura Y; Kawakami K; Takahashi H; Takemura M; Kitamura A; Someya K; Nakajima R
Bioorg Med Chem Lett; 2010 Jul; 20(13):3893-6. PubMed ID: 20605446
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and in vitro antifungal activity of 2-aryl-5-phenylsulfonyl-1,3,4-thiadiazole derivatives.
Foroumadi A; Daneshtalab M; Shafiee A
Arzneimittelforschung; 1999 Dec; 49(12):1035-8. PubMed ID: 10635451
[TBL] [Abstract][Full Text] [Related]
25. Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species.
Schmatz DM; Abruzzo G; Powles MA; McFadden DC; Balkovec JM; Black RM; Nollstadt K; Bartizal K
J Antibiot (Tokyo); 1992 Dec; 45(12):1886-91. PubMed ID: 1490879
[TBL] [Abstract][Full Text] [Related]
26. In vitro potency and fungicidal activity of CD101, a novel echinocandin, against recent clinical isolates of Candida spp.
Hall D; Bonifas R; Stapert L; Thwaites M; Shinabarger DL; Pillar CM
Diagn Microbiol Infect Dis; 2017 Nov; 89(3):205-211. PubMed ID: 28826987
[TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of novel pyrazino[2,1-a]isoquinolin derivatives with potent antifungal activity.
Tang H; Zheng CH; Zhu J; Fu BY; Zhou YJ; Lv JG
Arch Pharm (Weinheim); 2010 Jun; 343(6):360-6. PubMed ID: 20232375
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Extended-Interval Dosing of Micafungin Evaluated Using a Pharmacokinetic/Pharmacodynamic Study with Humanized Doses in Mice.
Lepak A; Marchillo K; VanHecker J; Azie N; Andes D
Antimicrob Agents Chemother; 2016 Jan; 60(1):674-7. PubMed ID: 26552968
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antifungal activity of novel isoxazolidine compounds.
Mullen GB; Swift PA; Bennett GA; DeCory TR; Maryniak DM; Dormer PG; St Georgiev V
Ann N Y Acad Sci; 1988; 544():32-45. PubMed ID: 3214072
[No Abstract] [Full Text] [Related]
30. Synthesis and antifungal activities of 5/6-arylamino-4,7-dioxobenzothiazoles.
Ryu CK; Kang HY; Yi YJ; Shin KH; Lee BH
Bioorg Med Chem Lett; 2000 Jul; 10(14):1589-91. PubMed ID: 10915058
[TBL] [Abstract][Full Text] [Related]
31. Syntheses and antifungal activities of novel 3-amido bearing pseudomycin analogues.
Zhang YZ; Sun X; Zeckner DJ; Sachs RK; Current WL; Gidda J; Rodriguez M; Chen SH
Bioorg Med Chem Lett; 2001 Apr; 11(7):903-7. PubMed ID: 11294388
[TBL] [Abstract][Full Text] [Related]
32. Design and synthesis of antifungal benzoheterocyclic derivatives by scaffold hopping.
Sheng C; Che X; Wang W; Wang S; Cao Y; Yao J; Miao Z; Zhang W
Eur J Med Chem; 2011 May; 46(5):1706-12. PubMed ID: 21411192
[TBL] [Abstract][Full Text] [Related]
33. Novel synthetic anti-fungal tripeptide effective against Candida krusei.
Gill K; Kumar S; Xess I; Dey S
Indian J Med Microbiol; 2015; 33(1):110-6. PubMed ID: 25560012
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antifungal activities of novel 1,3-beta-D-glucan synthase inhibitors. Part 2.
Masubuchi K; Okada T; Kohchi M; Murata T; Tsukazaki M; Kondoh O; Yamazaki T; Satoh Y; Ono Y; Tsukaguchi T; Kobayashi K; Ono N; Inoue T; Horii I; Shimma N
Bioorg Med Chem Lett; 2001 May; 11(10):1273-6. PubMed ID: 11392535
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antifungal activities of some new triazolylacetophenone derivatives.
Ertan R; Ayhan G; Yulug N; Rolland Y
Arzneimittelforschung; 1995 May; 45(5):620-3. PubMed ID: 7612065
[TBL] [Abstract][Full Text] [Related]
36. The pharmacology and clinical use of caspofungin.
Hope WW; Shoham S; Walsh TJ
Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):263-74. PubMed ID: 17428155
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological advances in the treatment of invasive candidiasis.
Deck DH; Guglielmo BJ
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):137-49. PubMed ID: 16441215
[TBL] [Abstract][Full Text] [Related]
38. Anidulafungin: a new echinocandin with a novel profile.
Vazquez JA
Clin Ther; 2005 Jun; 27(6):657-73. PubMed ID: 16117974
[TBL] [Abstract][Full Text] [Related]
39. A novel dodecapeptide from a combinatorial synthetic library exhibits potent antifungal activity and synergy with standard antimycotic agents.
Duggineni S; Srivastava G; Kundu B; Kumar M; Chaturvedi AK; Shukla PK
Int J Antimicrob Agents; 2007 Jan; 29(1):73-8. PubMed ID: 17156978
[TBL] [Abstract][Full Text] [Related]
40. In vitro antifungal evaluation and studies on the mode of action of xanthoxyline derivatives.
Pinheiro TR; Yunes RA; López SN; Santecchia CB; Zacchino SA; Cechinel Filho V
Arzneimittelforschung; 1999 Dec; 49(12):1039-43. PubMed ID: 10635452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
